Aficamten offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed aficamten's efficacy in improving exercise ...
What Is Myqorzo, and Why Does It Matter? Myqorzo (aficamten) is a new oral medicine approved by the FDA for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). It relieves symptoms ...
Gov.-elect Mikie Sherrill’s decisive victory gives her an important chance to set a new tone in Trenton. She made clear that opportunity and affordability will be at the top of her agenda, and many ...
A prospective homebuyer in New Jersey turned to Reddit for advice after their homeowners association's rules placed one of their top priorities for buying the property in jeopardy. The thread, posted ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved aficamten to improve functional capacity and symptoms in adults with obstructive hypertrophic ...
Harvard College released early action admissions decisions for the Class of 2030 on Thursday, welcoming a new group of students while once again withholding data on acceptance rates and applicant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback